| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | 144 |
| 13 Nov 2026 |
Form 4: Pardo Ryan, See Remarks
Sold 2,804,505 shares ($40.9M) |
| 13 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 |
Form 4: Miller Lisa K, Chief Operating Officer
Gave up 14,722 shares to cover exercise price or tax ($214K) · Sold 14,663 shares ($215K) |
| 12 Nov 2026 |
Form 4: Burdick Kenneth A, Director
Sold 66,589 shares ($960K) · Received 75,000 shares by exercise or conversion ($571K) · Sold 75,000 shares ($1.1M) · 1 more |
| 12 Nov 2026 |
8-K: Other Events
The stockholders listed in Schedule II hereto (the “Selling Stockholders”) of LifeStance Health Group, Inc., a Delaware corporation (the “Company”), severally propose to sell to the Underwriters named in Schedule I hereto (together, the ... |
| 12 Nov 2026 | 144 |
| 12 Nov 2026 | 144 |
| 10 Nov 2026 | 144 |
| 10 Nov 2026 | 144 |
| 10 Nov 2026 | 144 |
| 10 Nov 2026 | 424B7 |
| 09 Nov 2026 | 144 |
| 09 Nov 2026 | 424B7 |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
SCOTTSDALE, Ariz. – November 5, 2026 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2026. |
| 16 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 05 Oct 2026 | SCHEDULE 13G/A |
| 24 Sep 2026 |
Form 4: Bourdon David, Director
Gave 300,000 shares as a gift · Acquired 300,000 shares (Gift) |
Loading...